Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1986-12-15
1988-04-19
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
424DIG5, 424DIG10, 514857, 514859, 514861, 514862, 514865, 514889, 514919, 514969, A61K 748, A61K 907, A61K 3156
Patent
active
047389567
ABSTRACT:
A new and improved topically applied pharmaceutical preparation for the treatment of itching, rash, eczema, insect bites, poison ivy and the like and an improved vehicle for delivering the active ingredients thereof to the human skin in a manner whereby the bioavailability and percutaneous absorption of the active ingredient is remarkably enhanced. The vehicle comprises a volatile silicone, a fatty alcohol having from 12-22 carbon atoms, hydrocortisone; and such preservatives or emulsifying agents as may be warranted.
REFERENCES:
patent: 4496 (1985-01-01), Wong
patent: 4233295 (1980-11-01), Hill et al.
Jungermann Eric
Scott Richard A.
Wortzman Mitchell S.
Mybeck Richard R.
Neutrogena Corporation
Ore Dale R.
LandOfFree
Hydrocortisone composition having enhanced bioavailability and p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrocortisone composition having enhanced bioavailability and p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrocortisone composition having enhanced bioavailability and p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175315